{"id":"W2983732727","doi":"10.1016/j.jaad.2019.11.002","title":"Assessing perceived adverse effects of biologic medications for patients with psoriasis","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Mylan; Sun Pharma; Regeneron Pharmaceuticals; AbbVie; Celgene; Novartis; Sanofi; Almirall; Merck; Baxter International; GlaxoSmithKline; Wake Forest School of Medicine; Astellas Pharma US; Pfizer; Valeant Pharmaceuticals International; National Psoriasis Foundation; Galderma; Eli Lilly and Company; Boehringer Ingelheim; Merz Therapeutics","keywords":"Medicine; Adverse effect; Apremilast; Family medicine; Psoriasis; Etanercept; Secukinumab; Tazarotene; Dermatology; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001815976,0.0001816932,0.0003747626,0.000492744,0.0009630967,0.0009942752,0.0002686124,0.003144799,0.002672127],"category_scores_gemma":[0.01126237,0.0001454488,0.0003684962,0.0003860912,0.0003028221,0.0005456221,0.0003853328,0.002641658,0.0007292333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008911607,"about_ca_system_score_gemma":0.0007535754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00272698,"about_ca_topic_score_gemma":0.006150479,"domain_scores_codex":[0.9980294,0.001006109,0.0003622946,0.00007651236,0.0003457628,0.0001799589],"domain_scores_gemma":[0.9933415,0.003956242,0.0007492919,0.0001520645,0.001115419,0.0006853957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000713863,0.0006494682,0.7473445,0.0002100421,0.0001162907,0.02405084,0.001866194,0.0002016676,0.002303868,0.0007041645,0.1223869,0.09945224],"study_design_scores_gemma":[0.0005708618,0.002592254,0.7325172,0.0008854599,0.0003432432,0.08696388,0.0106401,0.003492523,0.002099784,0.003671185,0.1560747,0.0001487635],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.3481617,0.004283813,0.0005111771,0.5997869,0.004235508,0.0001386801,0.0004129749,0.0000452906,0.04242399],"genre_scores_gemma":[0.8321466,0.002432375,0.001094705,0.1501359,0.006582284,0.00006513696,0.0001372828,0.00001267507,0.007393032],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.003144799,"threshold_uncertainty_score":0.009603918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0337310059603791,"score_gpt":0.3772799866032641,"score_spread":0.343548980642885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}